TransDigm price target lowered to $1,490 from $1,534 at Truist

Truist lowered the firm’s price target on TransDigm (TDG) to $1,490 from $1,534 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results for Aerospace & Defense industry. The set up heading into the earnings season will be littered with unknowns, uncertainty, and what may turn out to be a lack of clarity from management teams regarding the outlooks for 2025 as tariff implications coupled with recessionary fears will likely have an impact on the cyclically-sensitive sector coverage, the analyst tells investors in a research note. Investors may be better served leaning into the more stable and predictable defense sector, especially against the backdrop of several favorable defense spending developments, Truist added.